drugset / Trial / NCT02453893
Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia
RandomizedParallel-groupTriple-blindTreatment
Summary
This research is a Randomized, double-blind, risperidone-controlled, multicenter clinical study. Chinese subjects with Ischemic Schizophrenia.
Timeline
- Start
- 2013-11
- Primary completion
- 2015-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iloperidone | Small molecule | 12 mg | Oral |
| Subject | Iloperidone | Small molecule | 24 mg | Oral |
| Comparator | Risperidone | Other / unclassified | 3 mg | Oral |
| Comparator | Risperidone | Other / unclassified | 6 mg | Oral |